Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia.

MLA

Giordano, Giulio, et al. “Medium Adsorbance Fraction of Reticulocyte and Myeloperoxidase Index May Individuate a Patient Subset with a Low Risk of Chemotherapy-Related Neutropenia.” Oncology Reports, vol. 21, no. 1, Jan. 2009, pp. 193–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19082461&authtype=sso&custid=ns315887.

APA

Giordano, G., Ferrucci, P. F., Nicci, C., Grafone, T., Tambaro, R., Papini, S., Farina, G., Piano, S., Zappacosta, B., & Storti, S. (2009). Medium adsorbance fraction of reticulocyte and myeloperoxidase index may individuate a patient subset with a low risk of chemotherapy-related neutropenia. Oncology Reports, 21(1), 193–198.

Chicago

Giordano, Giulio, Pier Francesco Ferrucci, Chiara Nicci, Tiziana Grafone, Rosa Tambaro, Stefano Papini, Giuliana Farina, Silvia Piano, Bruno Zappacosta, and Sergio Storti. 2009. “Medium Adsorbance Fraction of Reticulocyte and Myeloperoxidase Index May Individuate a Patient Subset with a Low Risk of Chemotherapy-Related Neutropenia.” Oncology Reports 21 (1): 193–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19082461&authtype=sso&custid=ns315887.